The Korean Journal of Gastroenterology (대한소화기학회지)

The Korean Society of Gastroenterology (대한소화기학회)
권호 표지

Current Status and Vaccine Indication for Hepatitis A Virus Infection in Korea

국내 A형간염의 현황과 백신 적응증

Jeong, Sook-Hyang
정숙향

  • Published : 20080600
⟨ Previous Next ⟩

Abstract

One of the major cause of recent acute viral hepatitis in Korean adults is hepatitis A virus (HAV) infection. Most of hepatitis A cases are young adults in their twenties or thirties, and the severity of the disease is related to the age of patients. The seroprevalence of HAV among the adolescents and young adults in their teens and twenties is about 10%, which suggests that a growing number of young adults are susceptible to HAV infection. Development of more adult cases with severe presentation is expected in the near future, and some preliminary data suggest the incidence rate of hepatitis A in Korea might be higher than 20/100,000 population. This clinical features and the epidemiological shift of HAV urge to promote childhood vaccination and consider catch-up vaccination for adolescents and young adults. More extensive evaluation on the nationwide epidemiology of HAV infection, cost-benefit analysis of HAV vaccination, and setting-up of guidelines for HAV vaccination are urgently warranted. (Korean J Gastroenterol 2008;51:331-337)

Keywords

References

  1. Lee HS, Byun JH, Kim CY. Etiology and outcome of acute viral hepatitis in Korean adults. J Korean Med Sci 1990;5: 149-154. https://doi.org/10.3346/jkms.1990.5.3.149
  2. Kang HM, Jeong SH, Kim JW, et al. Recent etiology and clinical features of acute viral hepatitis in a single center of Korea. Korean J Hepatol 2007;13:495-502. https://doi.org/10.3350/kjhep.2007.13.4.495
  3. Jeong SH, Hwang SG, Park SJ, Kang SK, Jee Y. Current status of acute viral hepatitis in Korea; epidemiology, clinical, virological characteristics, and the effects of antiviral treatment in severe acute hepatitis B and C - intrim report. Korean J Hepatol 2007;13:S101-S107.
  4. Lee DH, Cho YA, Park Y, et al. Hepatitis A in Korea: epidemiological shift and call for vaccine strategy. Intervirology 2008;51:70-74.
  5. Lee TH, Kim SM, Lee GS, et al. Clinical features of acute hepatitis A in the western part of Daejeon and Chungnam province: Single center experience. Korean J Gastroenterol 2006;47:136-143.
  6. Song KS, Kim JH, Kim YS, et al. Investigation about atypical clinical courses in patients with acute viral hepatitis A. Korean J Hepatol 2006;12:S80.
  7. Kim HS, Kim HS, Lee JY, et al. Initial thrombocytopenia as a simple, valuable predictor for clinical manifestation in acute hepatitis A. Scand J Gastroenterol 2008;43:81-888. https://doi.org/10.1080/00365520701514578
  8. Yoo HJ, Yoon BC, Han BH, et al. The clinical feature of acute hepatitis A and IgG anti-HAV seroprevalence of the Busan: Single center experience. Korean J Hepatol 2007; 13:S173.
  9. Kang CI, Choi CM, Park TS, Lee DJ, Oh MD, Choe KW. Incidence and seroprevalence of hepatitis A virus infection among young Korean soldiers. J Korean Med Sci 2007;22: 546-548. https://doi.org/10.3346/jkms.2007.22.3.546
  10. Eun JR, Lee HJ, Kim TN, Jang BI, Moon HJ. Clinical characteristics of adult patients with acute hepatitis A. Yeungnam Univ J Med 2007;24:170-178. https://doi.org/10.12701/yujm.2007.24.2.170
  11. Jung PJ, Kim DH, Joo IG, et al. Clinical characteristics of sporadic hepatitis A in Gwangju-Jeonnam province. Korean J Hepatol 2005;11:S65.
  12. Song HJ, Kim TH, Song JH, et al. Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea. J Korean Med Sci 2007;22:218-222. https://doi.org/10.3346/jkms.2007.22.2.218
  13. Jung CH, Lim YS, Kim KM, et al. Clinical outcome of 5 cases of fulminant hepatic failure caused by HAV. Korean J Hepatol 2006;12:S200.
  14. Park JY, Lee JB, Jeong SY, et al. Molecular characterization of an acute hepatitis A outbreak among healthcare workers at a Korean hospital. J Hosp Infect 2007;67:175-181. https://doi.org/10.1016/j.jhin.2007.07.020
  15. Hong WS, Kim CY. Seroepidemiology of type A and type B hepatitis in Seoul area. Korean J Intern Med 1982;25:19-26.
  16. Kim JH, Kang JH, Lee SY, et al. A study for seroprevalence of antibody to hepatitis A in Korea. Korean J Hepatol 2007; 13:S27.
  17. Song YB, Lee JH, Choi MS, et al. The age-specific seroprevalence of hepatitis A virus in Korea. Korean J Hepatol 2007;13:27-33.
  18. Kim DY, Ahn SH, Lee HW, et al. Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea. Eur J Gastroenterol Hepatol 2007;19:923-926. https://doi.org/10.1097/MEG.0b013e3282efa432
  19. Kim TY, Sohn JH, Ahn SB, et al. Comparison of recent IgG anti-HCV prevalence between two hospitals in Seoul and Gyeonggi area. Korean J Hepatol 2007;13:363-369. https://doi.org/10.3350/kjhep.2007.13.3.363
  20. Lee JM, Park HK, Choi KY, et al. Incidence and seroprevalence of hepatitis A virus among Korean auxiliary police officers. Infect Chemother 2007;39:292-295.
  21. Kwon YO, Choi IJ, Jung JW, Park JH. An epidemiologic study on the seropositive rate of hepatitis A virus among a selected group of children and adults in Busan. Korean J Pediatr 2007;50:262-267. https://doi.org/10.3345/kjp.2007.50.3.262
  22. Byun KS, Kim JH, Song KJ, et al. Molecular epidemiology of hepatitis A virus in Korea. J Gastroenterol Hepatol 2001; 16:519-524. https://doi.org/10.1046/j.1440-1746.2001.02481.x
  23. Bell BP. Prevention of hepatitis A virus, chapter 9. In: Thomas HC, Lemon S, Zuckerman AJ, ed. Viral hepatitis. 3rd ed. Oxford: Blackwell Publishing, 2005:126-145.
  24. Davis JP. Experience with hepatitis A and B vaccines. Am J Med 2005;118(suppl):S7-S15.
  25. Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007;357:1685-1694. https://doi.org/10.1056/NEJMoa070546
  26. Orr N, Klement E, Gillis D, et al. Long-term immunity in young adults after a single dose of inactivated hepatitis A vaccines. Vaccine 2006;24:4328-4332. https://doi.org/10.1016/j.vaccine.2006.03.010
  27. Jee YM, Go U, Cheon D, et al. Detection of hepatitis A virus from clotting factors implicated as a source of HAV infection among haemophilia patients in Korea. Epidemiol Infect 2006;134:87-93. https://doi.org/10.1017/S0950268805004632
  28. Almasio PL, Amoroso P. HAV infection in chronic liver disease: a rationale for vaccination. Vaccine 2003;21:2238-2241. https://doi.org/10.1016/S0264-410X(03)00139-7
  29. Rein DB, Hicks KA, Wirth KE, et al. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics 2007;119:12-21.